Catie BarrettAug 31, 20232 min readBiosynth Offers Novel Human Hybrid IgM Monoclonal Antibodies to Replace Natural Disease State PlasmaDublin, Ireland, 31st August 2023 – Biosynth Ltd, is delighted to offer the following innovative range of novel Human Hybrid IgM...
Claire DuffyAug 1, 20232 min readRebrand of Aalto Bio Reagents and Fitzgerald Industries International to BiosynthWe have collected some of the frequently asked questions related to our rebrand on August 1st, 2023, to ensure a smooth transition. For...
Catie BarrettJun 16, 20232 min readAalto Bio Reagents Launches Antibody to Cholera Toxin B Amidst Cholera Outbreak and Vaccine ShortageDublin, Ireland – 30th May 2023 - Aalto Bio Reagents, has recently launched their new Mouse Monoclonal Antibody (MAb) to Cholera Toxin B...
Rachel O'ReillyOct 10, 20222 min readAalto Bio Reagents Launches New Monkeypox Virus B21R-BSA Conjugate Peptides for Diagnostic TestingDublin, Ireland – 10th October 2022 - Aalto Bio Reagents Ltd., a leading global supplier of critical raw materials to the in-vitro...